Traders should expect the stock to trade near $27.00 adjusted for the time value of money and deal risk. Monitor for regulatory filings (HSR, German and Italian antitrust) and any competing bids. The spread may widen if regulatory concerns emerge, but the deal is not financing-contingent.
Price Chart
Executive Summary
Chiesi Farmaceutici will acquire KalVista for $27.00 per share in cash, valuing the company at approximately $1.9 billion. The offer represents a 36% premium to the 30-day VWAP, and the transaction is expected to close in Q3 2026, subject to regulatory approvals and minimum tender conditions.
Key Financial Metrics
Key Facts
- Offer price: $27.00 per share in cash
- Total equity value: ~$1.9 billion
- 36% premium to 30-day VWAP as of April 28, 2026
- Transaction not subject to financing condition
- Expected closing in Q3 2026
- Minimum tender condition: >50% of outstanding shares
- Termination fee: $66.4 million payable by KalVista in certain circumstances
- KalVista board unanimously approved and recommends shareholders tender
Financial Impact
KalVista shareholders will receive $27.00 per share, a 36% premium to recent trading levels, implying an enterprise value of approximately $1.9 billion.
Risk Factors
- Regulatory approvals from HSR, German Bundeskartellamt, and Italian foreign investment authorities
- Minimum tender condition (more than 50% of shares tendered)
- Potential competing superior proposal triggering termination fee
- Delays or failure to obtain necessary clearances
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-017656 |
| Document: ef20071670_8k.htm | 0001140361-26-017656 |
| Document: ef20071670_ex99-1.htm | 0001140361-26-017656 |
| Document: 0001140361-26-017656-index-headers.html | 0001140361-26-017656 |
| Document: 0001140361-26-017656-index.html | 0001140361-26-017656 |
| Document: 0001140361-26-017656.txt | 0001140361-26-017656 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 22, 2026 14w ago | 15-12G | — | awaiting T+1 | — | — |
Jun 17, 2026 15w ago | EFFECT | $27.00 awaiting T+1 | awaiting T+1 | — | — |
Jun 11, 2026 16w ago | 8-K | $26.99 awaiting T+1 | awaiting T+1 | — | — |
Jun 11, 2026 16w ago | Institutional Cluster | $27.00 $27.00 | · 0.00% | ▼ −0.54% | — |
May 19, 2026 19w ago | Insider Cluster | $26.81 $26.77 | ▲ +0.15% | ▲ +0.34% | — |
May 19, 2026 19w ago | Insider Cluster | $26.81 $26.77 | ▼ −0.15% | ▼ −0.34% | — |
Apr 29, 2026 22w ago | 8-K | $26.67 $26.66 | ▼ −0.04% | ▼ −1.06% | — |
Apr 17, 2026 24w ago | Insider Cluster | $20.48 $20.87 | ▼ −1.90% | ▼ −2.10% | — |
Feb 23, 2026 31w ago | Insider Cluster | $15.56 $15.77 | ▼ −1.35% | ▼ −0.61% | — |
Feb 23, 2026 31w ago | Insider Cluster | $15.56 $15.77 | ▼ −1.35% | ▼ −0.61% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access